PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/2374/12/10
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Anonymous v Pfizer
An anonymous complainant alleged Pfizer did not require some regional account directors (RADs) to sit and pass the ABPI Medical Representatives Examination.The complainant said RADs saw NHS custome…
2010 🔒 Subscribe
🔒 Subscribers only
AUTH/2201/1/09
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Novartis
AstraZeneca UK Limited complained about a UK press release (ref FEM08000117) issued by Novartis Pharmaceuticals UK Ltd, dated 11 December, headed: “Femara (letrozole) FIRST aromatase inhibitor to…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2197/1/09
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
MASTA
Sanofi Pasteur MSD complained about an email headed “Epaxal costings” sent by a MASTA representative to a customer in October 2008.Although framed as cost information, the email contained multi…
Clauses: 4.1,9.1,12.1
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2261/9/09
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
MSD breach of undertaking after withdrawn Cozaar banner reappeared in MIMS update (AUTH/2261/9/09)
Merck Sharp & Dohme (MSD) had previously given an undertaking in Case AUTH/2212/3/09 after a Cozaar (losartan) claim was ruled misleading.MSD instructed the publisher of MIMS Monthly Update to …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2256/8/09
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Napp
A health and social care board prescribing adviser complained about a Targinact (prolonged release oxycodone/naloxone) presentation on a Napp-sponsored website (www.targetingpain.co.uk).Slide 7 (�…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2249/7/09
Social Media & Digital Not Upheld 🏥 Musculoskeletal & Bone ▶ Video 🎙 Podcast
GSK Avodart
A consultant urological surgeon complained about GlaxoSmithKline (GSK) representatives promoting Avodart (dutasteride).In a meeting, the surgeon asked whether there had been any comparative studies…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2240/6/09
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche press release linked to lay press coverage of MabThera (rituximab) in early RA
A regulatory affairs consultant/scientist-writer complained about UK lay press articles (The Daily Telegraph and The Times) and TV coverage (16 June 2009) discussing early use of MabThera (rituxima…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2215/3/09
Social Media & Digital Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Merz v Allergan
Merz Pharma UK Ltd (marketing Xeomin) complained about Allergan Ltd’s promotion of Botox (botulinum neurotoxin).Two items were in scope: a product monograph (ref ACA/0343/2007/UK) and an objectio…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2212/3/09
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Takeda v Merck Sharp & Dohme
Takeda complained about a Merck Sharp & Dohme (MSD) advertisement for Cozaar (losartan) in The Pharmaceutical Journal (8 November) (ref 10-09 CZR.08.GB.10728.J). The ad compared antihypertensiv…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2273/10/09
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Lilly v Novo Nordisk
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2262/9/09
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Pfizer
A BMJ article (5 September 2009, “In clear sight”) criticised a meeting held at a five star hotel resort (March 2009) to encourage GPs to participate in a major cardiovascular safety study comp…
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2269/9/09
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breach of undertaking over The Times supplement remaining on website
The PMCPA Director identified information suggesting Novo Nordisk continued to use a supplement to The Times, contrary to an undertaking given in an earlier case (AUTH/2202/1/09).Novo Nordisk had p…
Clauses: 2
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2234/5/09
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk ruled in breach for repeated pre-licence promotion of Victoza (liraglutide) via website
Eli Lilly complained that Novo Nordisk continued to promote Victoza (liraglutide) before UK marketing authorisation, despite a recent prior ruling (AUTH/2202/1/09). Victoza marketing authorisation …
Clauses: NONE
2009 🔒 Subscribe
🔒 Subscribers only
AUTH/2124/5/08
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche Products Limited — MabThera (rituximab)
An anonymous consultant rheumatologist complained about a Roche-sponsored breakfast satellite symposium at the British Society of Rheumatology annual meeting in Liverpool on 23 April 2008.The sympo…
Clauses: 19.1,9.1,20.1
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2108/3/08
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Orphan Europe v Special Products and Chemical Developments
Orphan Europe complained about the Internet promotion of N-carbamyl-L-glutamic acid powder and anhydrous betaine powder by Special Products Limited and Chemical Developments Ltd.In November 2007, t…
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2151/7/08
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Lilly 40over40 erectile dysfunction awareness campaign
The Financial Times (29 July) criticised Lilly’s “40over40” erectile dysfunction (ED) awareness campaign; the Director took this up as a complaint under the Code.The campaign included televis…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2160/8/08
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Wyeth v Roche and Chugai
Wyeth complained about Roche Products Ltd and Chugai Pharma Europe Ltd media activities regarding unlicensed Actemra (tocilizumab), being co-developed for rheumatoid arthritis.Inter-company dialogu…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2139/7/08
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
A consultant rheumatologist complained about a meeting broadcast on the Internet from the Royal College of Physicians (RCP) on 19 June, sponsored by Roche Products Limited.The complainant queried R…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2123/5/08
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Sandoz
A general practitioner complained about large “junk” emails sent by/for Sandoz which filled clinical inboxes and slowed computers.The complainant said attempts to stop receipt were unsuccessful…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2115/4/08
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AUTH/2115/4/08 Roche v GlaxoSmithKline
Roche complained about two GlaxoSmithKline (GSK) corporate press releases for Tykerb/Tyverb (lapatinib) posted on www.gsk.com.Tykerb was licensed in the US; Tyverb was the registered brand name for…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2190/12/08
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
AstraZeneca
Two anonymous, non-contactable hospital health professionals complained about the conduct of the same AstraZeneca representative.Both alleged the representative initiated discussion about the unpub…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2145/7/08
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Guerbet
GE Healthcare complained about information on a website associated with Guerbet.The PMCPA considered whether the matter fell within the scope of the ABPI Code of Practice.
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2174/10/08
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Merck Serono
An anonymous, uncontactable complainant raised concerns about Merck Serono’s sponsorship of an “INSIGHTS” fertility nurse meeting (1–3 October 2008, Brighton).Allegations included: an after…
Clauses: NONE
2008 🔒 Subscribe
🔒 Subscribers only
AUTH/2171/9/08
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Abbott
Abbott voluntarily admitted that a sales representative sent an email about Synagis (palivizumab) to a number of health professionals that breached the ABPI Code.The email followed a meeting where …
Clauses: NONE
2008 🔒 Subscribe
← Prev 25 26 27 28 29 30 Next → Page 28 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews